Literature DB >> 7496150

Expression of the T antigen on a T-lymphoid cell line, supT1.

H Nakada1, M Inoue, N Tanaka, N Wakamiya, I Yamashina.   

Abstract

We have measured glycosyltransferase activities of SupT1 cells, a T-lymphoid cell line shown to react with autoantibodies in the sera of many HIV patients. Since considerable alpha-N-acetylgalactosaminyl-transferase and beta 1, 3 galactosyltransferase activities were found in SupT1 cells, at least the O-glycan core 1 structure can probably be synthesized. FACS analysis using an anti-T monoclonal antibody showed expression of the T antigen (Gal beta 1-3 GalNAc). Glycoproteins with the T antigen were isolated by immunoprecipitation with the anti-T antibody from a SupT1 cell lysate labelled metabolically with 3H-glucosamine and then analysed by SDS-PAGE. It was revealed that the precipitate contained a glycoprotein with a molecular weight corresponding to that of leukosialin. O-glycans were prepared from the immunoprecipitate by alkaline-borohydride treatment and then fractionated on Bio-Gel P-2, GalNAcOH and Gal-GalNAcOH being identified inter alia. These results suggest that an anti-T antibody may be included in the autoantibodies found in HIV-1 infected individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496150     DOI: 10.1007/BF00731338

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  16 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Targeted disruption of CD43 gene enhances T lymphocyte adhesion.

Authors:  N Manjunath; R S Johnson; D E Staunton; R Pasqualini; B Ardman
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

3.  Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples.

Authors:  J P Cartron; G Andreu; J Cartron; G W Bird; C Salmon; A Gerbal
Journal:  Eur J Biochem       Date:  1978-12-01

4.  Expression of the Tn antigen on T-lymphoid cell line Jurkat.

Authors:  H Nakada; M Inoue; N Tanaka; Y Numata; H Kitagawa; S Fukui; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

5.  Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128).

Authors:  H Nakada; Y Numata; M Inoue; N Tanaka; H Kitagawa; I Funakoshi; S Fukui; I Yamashina
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

6.  Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

Authors:  M Thurnher; S Rusconi; E G Berger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Purification and characterization of UDP-GalNAc:polypeptide N-acetylgalactosamine transferase from an ascites hepatoma, AH 66.

Authors:  M Sugiura; T Kawasaki; I Yamashina
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

8.  Mucin biosynthesis. Characterization of UDP-galactose: alpha-N-acetylgalactosaminide beta 3 galactosyltransferase from human tracheal epithelium.

Authors:  P W Cheng; S J Bona
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

9.  Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.

Authors:  S J Mentzer; E Remold-O'Donnell; M A Crimmins; B E Bierer; F S Rosen; S J Burakoff
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

10.  Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.

Authors:  B Ardman; M A Sikorski; M Settles; D E Staunton
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  1 in total

Review 1.  [Histomorphological patterns of regional lymph nodes in COVID-19 lungs].

Authors:  Jasmin D Haslbauer; Matthias S Matter; Anna K Stalder; Alexandar Tzankov
Journal:  Pathologe       Date:  2021-02-11       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.